UNSPSC 51101645: Chiniofon

This classification denotes an antiprotozoal agent with the molecular formula C9H6INO4S.CHO3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 98F8Y85B6W, chemically known as 5-quinolinesulfonic acid, 8-hydroxy-7-iodo- but generally known as chiniofon, which bears US NIH Compound Identifier 11042. European Medicines Agency schedules Chiniofon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12428MIG.

UNSPSC 51101645 Chiniofon, a Commodity code, covers pharmaceutical products and related health supplies that state and local governments procure for public health programs, emergency response, and community health initiatives. Recent state and local solicitations under this code show procurement of antibiotics, opioid antagonists, and drug deactivation systems — items acquired by public health departments, county health agencies, and emergency management programs to support disease prevention, overdose response, and controlled substance management. The buying bodies range from state health departments to county-level public health authorities, reflecting the distributed nature of pharmaceutical procurement across state and local jurisdictions.

Activity under the code appears in Illinois and Florida in the recent record. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under IFB 26482DPHPREPDB53392, posted August 28, 2026 with response due September 11, 2026 (completed award, not an open solicitation). Seminole County, Florida released IFB 60459723LAS on June 30, 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with deliveries to the Seminole County Community Health Building in Sanford; the bid response deadline was July 26, 2023.